)
)
CohBar Investor Relations Material
Latest events
M&A Announcement
CohBar
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from CohBar Inc
Access all reports
CohBar Inc. is a clinical-stage biotechnology company focused on developing therapeutics based on peptides derived from mitochondrial DNA. The company’s research centers on leveraging its proprietary mitochondrial peptide technology platform to address chronic and age-related diseases. CohBar’s pipeline targets conditions such as metabolic disorders, fibrotic diseases, cancer, and neurodegenerative diseases. The company is headquartered in Menlo Park, California, and its shares are listed on the NASDAQ Stock Exchange.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
CWBR
Country
🇺🇸 United States